Your browser doesn't support javascript.
loading
Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes.
Becker, Matthew W; Peters, Leeana D; Myint, Thinzar; Smurlick, Dylan; Powell, Andrece; Brusko, Todd M; Phelps, Edward A.
Affiliation
  • Becker MW; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
  • Peters LD; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Myint T; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.
  • Smurlick D; Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Powell A; University of Florida Diabetes Institute, University of Florida, Gainesville, FL, USA.
  • Brusko TM; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
  • Phelps EA; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL.
Sci Adv ; 9(22): eadg1082, 2023 06 02.
Article in En | MEDLINE | ID: mdl-37267353
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Extracellular Vesicles Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Extracellular Vesicles Limits: Humans Language: En Journal: Sci Adv Year: 2023 Document type: Article Country of publication: United States